RLB vs ERSP for Postoperative Analgesia in Lap Cholecystectomy
Retrolaminar Block Versus Erector Spinae Plane Block for Postoperative Analgesia in Laparoscopic Cholecystectomy: A Comparative Randomized Prospective Study
1 other identifier
interventional
100
1 country
1
Brief Summary
This prospective, randomized, double-blind clinical trial evaluates the comparative effectiveness of ultrasound-guided retrolaminar block (RLB) and erector spinae plane block (ESPB) for postoperative analgesia in patients undergoing laparoscopic cholecystectomy. A total of 100 ASA I-II patients, aged 20-60 years, will be randomly allocated into two equal groups to receive either RLB or ESPB bilaterally following induction of standardized general anesthesia. The primary outcome is the time to first request for rescue analgesia, while secondary outcomes include total morphine consumption within the first 24 hours, postoperative pain scores assessed using the Numeric Rating Scale (NRS), patient satisfaction, and the incidence of adverse events. Pain assessment will be performed at predefined intervals over the first 24 hours postoperatively. The study aims to determine which technique provides superior analgesia with reduced opioid requirements and improved patient outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
May 1, 2026
CompletedFirst Posted
Study publicly available on registry
May 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2027
May 20, 2026
May 1, 2026
1.4 years
May 1, 2026
May 18, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Time to the 1st rescue analgesia
in the 1st 24hr.
Secondary Outcomes (3)
Total morphine consumption
in the 1st 24hr.
Pain score.
Pain will be assessed at, 2, 4, 6, 8, 12, 18 and 24 hour postoperatively.
Degree of patient satisfaction
in the first 24 hours after surgery
Study Arms (2)
RLB group
ACTIVE COMPARATORESPB group
ACTIVE COMPARATORInterventions
Patients will be positioned laterally, and a curved ultrasound probe will be aligned longitudinally at the T7 vertebra. The vertebral lamina and spinous process will be identified. A needle will be inserted 1 - 1.5 cm lateral to the spinous process, advanced toward the lamina, and 20 mL of LA mixture will be injected into the fascial plane between the lamina and transversus spinae muscles bilaterally.
The blocks will be conducted at the level of the T7 spinous process (SP) with the patient in the lateral position and the arm abducted. Using US ( curved probe ) , the T7 transverse process (TP) is identified by counting from the 12th rib. The US probe is positioned 2 - 3 cm laterally to the SP of T7 and situated over the TP of T7/T8 in the parasagittal longitudinal plane, with the erector spinae muscle (ESM) visualized over the TP. The needle is then inserted and advanced in plane from cephalad to caudad until the needle tip contacts the TP of T7. Following hydro dissection with 2 mL of isotonic saline, which elevates the ESM, 20 mL of LA mixture is administered after several negative aspirations.
Eligibility Criteria
You may qualify if:
- Age from 20 to 60 years.
- Both sexes.
- American Society of Anesthesiology (ASA) grade I and II physical status.
- Patients will undergo cholecystectomy under general anesthesia.
You may not qualify if:
- Sensitivities or contraindications to the study medications.
- Infection at the site of injection.
- Emergency surgery.
- Body mass index (BMI) \> 35.
- Organic comorbidities.
- Histories of psychological conditions and/or chronic pain syndromes.
- Contraindications to regional anesthesia.
- Severe respiratory, cardiac, hepatic and renal disorders.
- Pregnancy.
- Coagulopathy.
- Opioid addiction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag Faculty of Medicine
Sohag, Egypt
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident of Anesthesia, Surgical Intensive Care and Pain Management Faculty of Medicine, Sohag University
Study Record Dates
First Submitted
May 1, 2026
First Posted
May 20, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 1, 2027
Last Updated
May 20, 2026
Record last verified: 2026-05